López-Ozuna VM - Search Results

1

Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients' outcome: A STROBE-compliant article.

Sami MM, Hachim MY, Hachim IY, Elbarkouky AH, López-Ozuna VM. Sami MM, et al. Among authors: lopez ozuna vm. Medicine (Baltimore). 2019 Mar;98(9):e14744. doi: 10.1097/MD.0000000000014744. Medicine (Baltimore). 2019. PMID: 30817632 Free PMC article.

2

Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.

López-Ozuna VM, Hachim IY, Hachim MY, Lebrun JJ, Ali S. López-Ozuna VM, et al. Sci Rep. 2016 Aug 2;6:30934. doi: 10.1038/srep30934. Sci Rep. 2016. PMID: 27480353 Free PMC article.

3

Prolactin modulates TNBC aggressive phenotype limiting tumorigenesis.

López-Ozuna VM, Hachim IY, Hachim MY, Lebrun JJ, Ali S. López-Ozuna VM, et al. Endocr Relat Cancer. 2019 Mar;26(3):321-337. doi: 10.1530/ERC-18-0523. Endocr Relat Cancer. 2019. PMID: 30640712

4

Concomitant Expression of Prolactin Receptor and TGFβ Receptors in Breast Cancer: Association with Less Aggressive Phenotype and Favorable Patient Outcome.

Hachim IY, López-Ozuna VM, Hachim MY, Lebrun JJ, Ali S. Hachim IY, et al. Among authors: lopez ozuna vm. Int J Mol Sci. 2019 Apr 2;20(7):1640. doi: 10.3390/ijms20071640. Int J Mol Sci. 2019. PMID: 30987013 Free PMC article.

5

A dual prognostic role for the TGFβ receptors in human breast cancer.

Hachim IY, Hachim MY, López-Ozuna VM, Ali S, Lebrun JJ. Hachim IY, et al. Hum Pathol. 2016 Nov;57:140-151. doi: 10.1016/j.humpath.2016.07.002. Epub 2016 Jul 19. Hum Pathol. 2016. PMID: 27445263

6

Prolactin hormone exerts anti-tumorigenic effects in HER-2 overexpressing breast cancer cells through regulation of stemness.

Hachim IY, López-Ozuna VM, Hachim MY, Lebrun JJ, Ali S. Hachim IY, et al. Among authors: lopez ozuna vm. Stem Cell Res. 2019 Oct;40:101538. doi: 10.1016/j.scr.2019.101538. Epub 2019 Aug 18. Stem Cell Res. 2019. PMID: 31450192 Free article.

7

Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer.

López-Ozuna VM, Kogan L, Hachim MY, Matanes E, Hachim IY, Mitric C, Kiow LLC, Lau S, Salvador S, Yasmeen A, Gotlieb WH. López-Ozuna VM, et al. Front Oncol. 2021 Jul 7;11:695404. doi: 10.3389/fonc.2021.695404. eCollection 2021. Front Oncol. 2021. PMID: 34307159 Free PMC article.

8

The Molecular Basis of Gender Variations in Mortality Rates Associated With the Novel Coronavirus (COVID-19) Outbreak.

Hachim IY, Hachim MY, Talaat IM, López-Ozuna VM, Saheb Sharif-Askari N, Al Heialy S, Halwani R, Hamid Q. Hachim IY, et al. Among authors: lopez ozuna vm. Front Mol Biosci. 2021 Sep 17;8:728409. doi: 10.3389/fmolb.2021.728409. eCollection 2021. Front Mol Biosci. 2021. PMID: 34604307 Free PMC article.

9

The impact of wait times on oncological outcome in high-risk patients with endometrial cancer.

Mitric C, Matanes E, Wissing M, Amajoud Z, Abitbol J, Yasmeen A, López-Ozuna V, Eisenberg N, Laskov I, Lau S, Salvador S, Gotlieb WH, Kogan L. Mitric C, et al. J Surg Oncol. 2020 Aug;122(2):306-314. doi: 10.1002/jso.25929. Epub 2020 Apr 14. J Surg Oncol. 2020. PMID: 32291783

10

Biguanides in combination with olaparib limits tumorigenesis of drug-resistant ovarian cancer cells through inhibition of Snail.

Wang Q, López-Ozuna VM, Baloch T, Bithras J, Amin O, Kessous R, Kogan L, Laskov I, Yasmeen A. Wang Q, et al. Among authors: lopez ozuna vm. Cancer Med. 2020 Feb;9(4):1307-1320. doi: 10.1002/cam4.2738. Epub 2019 Dec 21. Cancer Med. 2020. PMID: 31863638 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters